A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours

European Journal of Cancer

Volumn 29, Issue 11, 1993, Pages 1589-1592

  Prévost, Grégoire ^a   Provost, Philippe ^a   Sallé, Valérie ^a   Lanson, Monique ^b   Thomas, François ^c  

^a UNIVERSITÉ PARIS 13   (France)

^b Laboratoire de Biologie des tumeurs 2 bis Boulevard Tonnelle 37032 Tours France ^*

^c IPSEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; HORMONE RECEPTOR; SOMATOSTATIN DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMAN; MALE; MIDDLE AGE; MOLECULAR WEIGHT; OLIGOPEPTIDES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T;

EID: 0027250772     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(93)90300-5     Document Type: Article

References (19)

1. Hypothalamic polypeptides that inhibit the secretion of immunoreactive pituitary growth hormone
2. Les analogues de la somatostatine en cancérologie
3. Molecular heterogeneity of somatostatin analogue BIM-23014C receptors in human breast carcinoma cells using the chemical cross-linking assay.
4. Growth of human breast cancer cells inhibited by the somatostatin analog BIM-23014C (Somatuline)
5. In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue
6. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase
7. Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration
8. The role of somatostatin and its analogs in the diagnosis and treatments of tumors
9. Evidence for multiple protein constituents of the somatostatin receptor in pituitary Tumour cells: affinity cross-linking and molecular characterization
10. Differential binding of somatostatin agonists to brain and adenohypophysis
11. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney
12. Comparison of somatuline (BIM-23014) and somatostatin on endocrine and exocrine activities in the rat
13. Characteristics and distribution of receptors for (D-Trp6)-luteinizing releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
14. Prognostic value of receptors for IGF, somatostatin, and EGF in human breast cancer
15. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors
16. Tissue specific distribution of cross-linked somatostatin receptor proteins in the rat
17. Characterization of 17-β oestradiol dependent and independent somatostatin receptor subtypes in rat anterior pituitary
18. 17 β-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells
19. Somatuline, a somatostatin analog, inhibits the growth of human and rat breast cancer cell lines in vivo